Amelioration of Experimental Autoimmune Encephalomyelitis in Lewis Rats by FTY720 Treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Amelioration of Experimental Autoimmune Encephalomyelitis in Lewis Rats by FTY720 Treatment

Published:2003-01-21 Issue:1 Volume:305 Page:70-77
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Fujino Masayuki,Funeshima Naoko,Kitazawa Yusuke,Kimura Hiromitsu,Amemiya Hiroshi,Suzuki Seiichi,Li Xiao-Kang

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference40 articles.

1. Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype

2. The efficacy of cyclosporin A, FK-506 and Prednisolone to modify the adoptive transfer of Experimental Allergic Encephalomyelitis (EAE)

3. The effect of cyclosporin A on the adoptive transfer of experimental allergic encephalomyelitis in the Lewis rat.;Bolton;Clin Exp Immunol,1982

4. Immunosuppression by cyclosporin a of experimental allergic encephalomyelitis

5. Cell death during autoimmune demyelination: effector but not target cells are eliminated by apoptosis.;Bonetti;J Immunol,1997

Cited by 256 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing Spns2-dependent S1P Transport as a Prospective Therapeutic Target;2024-03-29

2. Resting‐state functional magnetic resonance imaging reveals functional connectivity alteration in the experimental autoimmune encephalomyelitis model of multiple sclerosis;NMR in Biomedicine;2024-03-07

3. Molecular and neuroimmune pharmacology of S1P receptor modulators and other disease-modifying therapies for multiple sclerosis;Pharmacology & Therapeutics;2023-06

4. Experimental encephalomyelitis at age 90, still relevant and elucidating how viruses trigger disease;Journal of Experimental Medicine;2023-01-18

5. Repurposing MS immunotherapies for CIDP and other autoimmune neuropathies: unfulfilled promise or efficient strategy?;Therapeutic Advances in Neurological Disorders;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3